US News & World Report Rates University of Florida Health As High Performing for Maternity Care
UF Health Shands Hospital received the highest possible rating for its services in the U.S. News & World Report rankings for the Best Hospitals for Maternity Care.
LightPath Technologies Begins Sustained Delivery of Infrared Assemblies to European Defense Customer
UF startup LightPath Technologies, Inc. announced that it has begun sustained delivery of infrared lens assemblies per the terms of the October 2024 Letter of Intent from a European defense customer for active duty use in first-person view (FPV) drone applications.
Purpose Beyond a Cure: Advancing Hodgkin Lymphoma Treatment
UF researcher William Slayton has led clinical trials that aim to reduce the burden of side effects for Hodgkin lymphoma patients like Emilie Lynch, who has passed the 5-year milestone considered a yardstick for being cured.
UF Medicine Research Shows the Role of Diet in Developing Liver Inflammation
UF researcher Matthew Merritt has published research describing a novel method for detecting metabolic dysfunction-associated steatotic liver disease (MASLD) in the journal Cell Reports Medicine.
Islam Named Yangbin Wang Endowed Rising Star Professor
UF researcher Md Jahidul Islam, an ECE Assistant Professor, has been named the Yangbin Wang Rising Star Professor in recognition of his cutting-edge research and impactful student mentoring.
Runners Who Wear These Shoes Are More Likely To Get Injured
UF researchers found that runners wearing thick-heeled sneakers were more likely to sustain injuries compared to those wearing flatter shoes.
AI-Powered Avatars Transform Training for Nurse Practitioners and Dentists
UF researcher Michael Bumbach has developed an AI-powered simulation program that uses avatars, virtual reality, and real-time feedback to help nursing and dental professionals.
Clinician Training Program Leads to Better Outcomes for Patients With Diabetes
UF researchers find that a tele-education program for health care providers who treat people with diabetes resulted in significant improvements in patient outcomes.
Atsena Therapeutics Announces Dosing Completed in Part A of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced dosing has been completed in Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
A Bacterial Toxin That Promotes Colorectal Cancer Metastasis
UF researcher Christian Jobin’s study suggests that microbial cells in the gut can influence human health, with some contributing to colorectal cancer metastasis.